Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism

被引:35
作者
Gibbs, J
Flores, CM
Hargreaves, KM
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Endodont, San Antonio, TX 78229 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA
关键词
superfusion; pain; spinal cord; dorsal root; ganglion; exocytosis;
D O I
10.1016/j.neuroscience.2004.01.044
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuropeptide Y (NPY) is expressed in certain primary afferent fibers, is up-regulated in response to tissue injury and is capable of inhibiting nociceptive behavior at the spinal level. However, the spinal mechanism(s) for NPY-evoked antinociception is unknown. In this study, we evaluated the hypothesis that agonists at the NPY Y1 receptor subtype (Y1-R) inhibit exocytosis from the capsaicin-sensitive class of nociceptors. Using in vitro superfusion of rat dorsal spinal cord slices, pre-treatment with the Y1-R agonist [Leu(31) Pro(34)]NPY significantly inhibited capsaicin-evoked release of immunoreactive calcitonin gene-related peptide with an EC50 value of 10.6 nM. This inhibitory effect was concentration dependent, significantly attenuated by pre-treatment with the Y1 receptor antagonist BIBP3226 and reproduced by synthetic NPY. Examination of adult rat dorsal root ganglia using double immunofluorescent labeling revealed frequent co-localization of Y1 receptor immunoreactivity in vanilloid receptor type 1-immunoreactive neurons, indicating that Y1 agonists may directly modulate the capsaicin-sensitive class of nociceptors. Collectively, these results indicate that NPY is capable of inhibiting capsaicin-sensitive neurons via a Y1 receptor mechanism, suggesting the mechanisms for spinal NPY-induced antinociception is due, at least in part, to inhibition of central terminals of capsaicin-sensitive nociceptors. (C) 2004 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:703 / 709
页数:7
相关论文
共 46 条
[1]   Neuropeptide Y family of hormones: Receptor subtypes and antagonists [J].
Balasubramaniam, A .
PEPTIDES, 1997, 18 (03) :445-457
[2]   Y-receptor subtypes - How many more? [J].
Blomqvist, AG ;
Herzog, H .
TRENDS IN NEUROSCIENCES, 1997, 20 (07) :294-298
[3]   NPYY1 receptors are present in axonal processes of DRG neurons [J].
Brumovsky, PR ;
Shi, TJ ;
Matsuda, H ;
Kopp, J ;
Villar, MJ ;
Hökfelt, T .
EXPERIMENTAL NEUROLOGY, 2002, 174 (01) :1-10
[4]   EFFECTS OF INTRATHECAL ADMINISTRATION OF NEUROPEPTIDES ON A SPINAL NOCICEPTIVE REFLEX IN THE RAT - VIP, GALANIN, CGRP, TRH, SOMATOSTATIN AND ANGIOTENSIN-II [J].
CRIDLAND, RA ;
HENRY, JL .
NEUROPEPTIDES, 1988, 11 (01) :23-32
[5]   BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: A review of its pharmacological properties [J].
Doods, HN ;
Wieland, HA ;
Engel, W ;
Eberlein, W ;
Willim, KD ;
Entzeroth, M ;
Wienen, W ;
Rudolf, K .
REGULATORY PEPTIDES, 1996, 65 (01) :71-77
[6]   MICROINJECTION OF NEUROPEPTIDE-Y INTO THE SUPERFICIAL DORSAL HORN REDUCES STIMULUS-EVOKED RELEASE OF IMMUNOREACTIVE SUBSTANCE-P IN THE ANESTHETIZED CAT [J].
DUGGAN, AW ;
HOPE, PJ ;
LANG, CW .
NEUROSCIENCE, 1991, 44 (03) :733-740
[7]   ENHANCED RELEASE OF IMMUNOREACTIVE CGRP AND SUBSTANCE-P FROM SPINAL DORSAL HORN SLICES OCCURS DURING CARRAGEENAN INFLAMMATION [J].
GARRY, MG ;
HARGREAVES, KM .
BRAIN RESEARCH, 1992, 582 (01) :139-142
[8]  
GARRY MG, 1994, J NEUROSCI, V14, P4329
[9]   Involvement of spinal calcitonin gene-related peptide in the development of acute visceral hyperalgesia in the rat [J].
Gschossmann, JM ;
Coutinho, SV ;
Miller, JC ;
Huebel, K ;
Naliboff, B ;
Wong, HC ;
Walsh, JH ;
Mayer, EA .
NEUROGASTROENTEROLOGY AND MOTILITY, 2001, 13 (03) :229-236
[10]   Immunocytochemical localization of the vanilloid receptor 1 (VR1):: relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites [J].
Guo, A ;
Vulchanova, L ;
Wang, J ;
Li, X ;
Elde, R .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (03) :946-958